My PhD Journey in the U.S. | Week 82 | 03/08/2026 – 03/14/2026
Pivot Week
https://link.springer.com/article/10.1038/s44320-026-00189-7 Predicting the protein interaction landscape of a free-living bacterium with pooled-AlphaFold3 Key figures Figure 2: Establishes the two core technical claims of the paper, namely the size bias…
https://www.nature.com/articles/s41467-021-25735-9 A rational blueprint for the design of chemically-controlled protein switches Key figures [Figure 4]: It is the central conceptual advance because it shows how OFF-switch CDHs were converted into…
https://www.biorxiv.org/content/10.64898/2026.03.03.707476v1 Explainable Physicochemical Determinants of Protein–Ligand Binding via Non-Covalent Interactions Key figures [Figure 1]: Establishes the main contribution by pairing InteractBind dataset construction with ExplainBind’s attention-supervised sequence model, making the…
https://www.pnas.org/doi/10.1073/pnas.1911154117 A conformation-specific ON-switch for controlling CAR T cells with an orally available drug Key figures [Figure 2E]: Quantifies drug-dependent dynamic range (nanomolar ON vs micromolar OFF) and cross-validates switching…
https://www.nature.com/articles/s41592-020-0746-7 Chemogenetic Control of Nanobodies Key figures [Fig. 1]: Defines the LAMA design principle (cpDHFR insertion into nanobody CDRs) and demonstrates ligand-triggered loss of target binding with reversible kinetics and…
https://www.nature.com/articles/s41467-020-20671-6 Direct control of CAR T cells through small molecule-regulated antibodies Key figures [Figure 3]: Establishes that a single-module “conditional CAR” retains potent target killing yet is reversibly and dose-dependently…